KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers

Shuo Wang1, Jiang Chen1, Xiao-Zhong Guo2

  • 1Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang 110840, Liaoning Province, China.

Insights

The KAI1/CD82 gene may suppress cancer metastasis by regulating the autotaxin (ATX)-lysophosphatidic acid (LPA) pathway. Understanding this mechanism offers potential for targeted gastrointestinal cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumorigenesis involves cell metabolism dysregulation, impacting cancer occurrence, development, and metastasis.
  • KAI1/CD82 is a metastasis suppressor gene correlated with tumor invasion and prognosis.
  • Lysophosphatidic acid (LPA) and its regulator, autotaxin (ATX), are implicated in tumor progression, particularly in gastrointestinal cancers.

Purpose of the Study:

  • To review the molecular mechanisms of the KAI1/CD82 gene and the ATX-LPA axis in cancer.
  • To explore their roles in gastrointestinal tumor invasion, metastasis, and prognosis.
  • To investigate the potential of targeting the ATX-LPA axis for cancer therapy.

Main Methods:

  • Literature review of KAI1/CD82 gene and ATX-LPA axis functions.
  • Analysis of their roles in gastrointestinal cancer development and progression.
  • Exploration of potential therapeutic strategies targeting this pathway.

Main Results:

  • KAI1/CD82 is a key inhibitor of metastasis across various tumors.
  • The ATX-LPA signaling pathway is frequently dysregulated in gastrointestinal tumors.
  • Pre-experimental data suggest KAI1/CD82 regulates cancer cell migration via the ATX-LPA axis.

Conclusions:

  • The KAI1/CD82 gene's role in inhibiting metastasis may involve modulation of the ATX-LPA axis.
  • Further research into this mechanism could provide a basis for novel targeted cancer therapies.
  • Understanding KAI1/CD82 and ATX-LPA interactions is crucial for advancing gastrointestinal cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
48.4K